Cited by 23Genomics and Chromatin DynamicsChromatin Remodeling and CancerEpigenetics and DNA Methylation

RepliChrom: Interpretable machine learning predicts cancer‐associated enhancer‐promoter interactions using DNA replication timing

Open access
Dao, Fuying, Lebeau, Benjamin, Ling, Crystal Chia Yin, Yang, Mi, Xie, Xueqin, Fullwood, Melissa Jane, Lin, Hao, Lyu, Hao·2025·iMeta

Abstract

RepliChrom is an interpretable machine learning model that predicts enhancer-promoter interactions using DNA replication timing across multiple cell types. By integrating replication timing with chromatin interaction data from multiple experimental platforms, it accurately distinguishes true interactions and reveals promoter-region signals as key regulatory drivers. Importantly, the RepliChrom uncovers cancer-specific chromatin patterns in leukemia, offering mechanistic insights into how replication timing shapes long-range gene regulation in both normal and diseased genomes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/imt2.70052

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Traditional ML algorithms have been the cornerstone of early AI-assisted diagnostic models, particularly demonstrating robust performance in scenarios where features are well defined and sample sizes are moderate.

    “Traditional ML algorithms have been the cornerstone of early AI-assisted diagnostic models [106–110], particularly demonstrating robust performance in scenarios where features are well defined and sample sizes are moderate.”

    From Artificial intelligence-powered prediction of diabetic complications: from clinical data to molecular omics (2026) · cites this paper as [106]

    In Results and Discussion (page unavailable), the paper reports that a random-forest model performed best among the algorithms compared, likely because its replication-timing features were relatively simple. This supports robust performance with low-complexity features for enhancer–promoter interaction prediction, but the paper does not establish that traditional ML was a cornerstone of early AI-assisted diagnostic models or that its performance depended on moderate sample sizes. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dao, F., Lebeau, B., Ling, C. C. Y., Yang, M., Xie, X., Fullwood, M. J., Lin, H., & Lyu, H.
Affiliations
  • University of Electronic Science and Technology of China (CN)
  • Nanyang Technological University (SG)
  • Agency for Science, Technology and Research (SG)
  • Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Life Science and Technology University of Electronic Science and Technology of China Chengdu China
Corresponding author
  • Fullwood, Melissa Jane
  • Lin, Hao
Venue
iMeta
Publisher
Wiley
Published
2025-05-27
Volume
4
Issue
4
Pages
e70052-e70052
ISSN
  • 2770-596X (ISSN-L)
  • 2770-5986
OpenAlex
W4410788995
Cited by
23
References
20
Citations by year
2026: 16 · 2025: 7
FWCI
6.91
Type
journal article
Language
en
Open access
Locations
  • iMeta (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DR-NTU (Nanyang Technological University) (publishedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • China Postdoctoral Science Foundation (2023TQ0047, GZC20230380)
  • National Natural Science Foundation of China (62172078, 62402089)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
enhancer-promoter interactions, DNA replication timing, long-range chromatin interactions, cancer, leukemia, model interpretability, chromatin regulation, cell type specificity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review